Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$681K Sell
5,660
-5,986
-51% -$691K 0.77% 42
2025
Q4
$1.23M Buy
+11,646
New +$1.09M 1.4% 23
2024
Q3
$1.36M Hold
11,988
1.82% 11
2024
Q2
$1.48M Sell
11,988
-224
-2% -$28.9K 1.71% 11
2024
Q1
$1.61M Buy
+12,212
New +$1.51M 1.75% 8

Other funds holding MRK

Verdad Advisers's MRK Position: Q1 2026 in Review

Verdad Advisers reduced its Merck (MRK) stake by 51% in Q1 2026, selling an estimated $691K and leaving 5,660 shares worth $681K. The position accounts for 0.77% of the portfolio, ranked #42.

Verdad Advisers first reported a position in MRK in Q1 2024 and has held it in 5 quarters since. The position peaked at $1.61M in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Verdad Advisers held 5,660 shares of Merck worth $681K as of Q1 2026.
  • Verdad Advisers sold 5,986 Merck shares in Q1 2026, an estimated $691K.
  • Merck made up 0.77% of Verdad Advisers's portfolio in Q1 2026, its #42 holding.
  • Verdad Advisers first reported a position in Merck in Q1 2024 and has held it in 5 quarters since.
  • Verdad Advisers's Merck position peaked at $1.61M in Q1 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Verdad Advisers's 13F filing for Q1 2026, filed 15 May 2026.